Sustainable productivity and employability

Thema:
Healthy society

The Sustainable Productivity and Employability expertise group improves sustainable labour productivity in organisations. By sustainable, we mean that solutions are in line with what contributes to the health of employees, but also with what organisations need in order to survive in a healthy way.

Healthy labour is the best building block for organisations. This can be achieved by utilising the possibilities of new technologies and the latest organisational developments. We bring the conception and implementation of these solutions together under the heading of ‘social innovation’.

Sustainable labour productivity

Measuring productivity that lasts is difficult. Nevertheless, we have done a lot of research on this at TNO. In healthcare, industry, business services, and government.

We use measuring methods that combine social organisation issues and knowledge of human factors (ergonomics). We help companies and organisations at home and abroad to increase their productivity, health, employee comfort, and development opportunities.

Downloads

Balanced flexibility: 10 practical examples

Learn how your organisation can take a conscious approach to flexibility to reduce risks and increase opportunities

Get inspired

13 resultaten, getoond 1 t/m 5

TNO helps accelerate drug development through insight

Informatietype:
Insight
14 November 2022

To find the most effective interventions for complex metabolic diseases, we must first understand the dynamics of disease onset and progression. Only then can key targets and optimal therapeutic windows for more effective treatment be defined. We spoke with Anita van den Hoek, Research Scientist for TNO Metabolic Health, about how TNO helps pharmaceutical companies accelerate drug development through better understanding of disease pathways.

TNO proves method for effective pediatric drug development

Informatietype:
Insight
14 November 2022

Safe and effective drug dosing for young children come with their own challenges. Up to the age of 18, a child’s metabolism can change significantly. And in the first two years of life, those ontogenic differences can be rapid and dramatic. TNO published its findings from the first drug disposition (mass balance/metabolite profiling) study to conclusively prove that microtracing with accelerator mass spectrometry (AMS) is an effective way to collect clinical data in these young patients. This AMS technology can also be the key to building up more data on drug interventions in pregnant and lactating mothers.

Translational models TNO excel in preclinical research

Informatietype:
Insight
13 June 2022
TNO’s animal models for NAFLD/NASH are the most translational to human tissue data in a recent Hepatology article about NAFLD/NASH and cardiovascular disease.

Public Private Partnership Arla Food Ingredients and Danone

Informatietype:
Insight
17 March 2022
TNO Healthy Living, Arla & Danone built an in silico model to identify markers needed to assess safety & efficacy of an immune intervention in infants.

International Women’s Day 2022

Informatietype:
Insight
8 March 2022

Today on International Women’s Day we celebrate the success and achievements of women in science for breaking down barriers and challenging the status quo. Get to know some of TNO’s women contributing to a sustainable society every day.